These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29380400)

  • 1. Ursolic acid derivatives as potential antidiabetic agents: In vitro, in vivo, and in silico studies.
    Guzmán-Ávila R; Flores-Morales V; Paoli P; Camici G; Ramírez-Espinosa JJ; Cerón-Romero L; Navarrete-Vázquez G; Hidalgo-Figueroa S; Yolanda Rios M; Villalobos-Molina R; Estrada-Soto S
    Drug Dev Res; 2018 Mar; 79(2):70-80. PubMed ID: 29380400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.
    Cerón-Romero L; Paoli P; Camici G; Flores-Morales V; Rios MY; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2018-22. PubMed ID: 26961283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
    Ramírez-Espinosa JJ; Rios MY; López-Martínez S; López-Vallejo F; Medina-Franco JL; Paoli P; Camici G; Navarrete-Vázquez G; Ortiz-Andrade R; Estrada-Soto S
    Eur J Med Chem; 2011 Jun; 46(6):2243-51. PubMed ID: 21453996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies.
    Choi JS; Ali MY; Jung HA; Oh SH; Choi RJ; Kim EJ
    J Ethnopharmacol; 2015 Aug; 171():28-36. PubMed ID: 26027757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and molecular docking studies of pimarane-type diterpenes as protein tyrosine phosphatase (PTP1B) inhibitors from Aralia continentalis roots.
    Jung HA; Cho YS; Oh SH; Lee S; Min BS; Moon KH; Choi JS
    Arch Pharm Res; 2013 Aug; 36(8):957-65. PubMed ID: 23604820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Apr; 10(4):897-906. PubMed ID: 11836096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
    Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
    Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase 1B inhibitors isolated from Artemisia roxburghiana.
    Shah MR; Ishtiaq ; Hizbullah SM; Habtemariam S; Zarrelli A; Muhammad A; Collina S; Khan I
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):563-7. PubMed ID: 26118418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
    Kumar A; Ahmad P; Maurya RA; Singh AB; Srivastava AK
    Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
    Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
    Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes.
    Xu Q; Luo J; Wu N; Zhang R; Shi D
    Int J Biol Macromol; 2018 Jan; 106():379-386. PubMed ID: 28811203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies.
    Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors.
    Navarrete-Vazquez G; Ramírez-Martínez M; Estrada-Soto S; Nava-Zuazo C; Paoli P; Camici G; Escalante-García J; Medina-Franco JL; López-Vallejo F; Ortiz-Andrade R
    Eur J Med Chem; 2012 Jul; 53():346-55. PubMed ID: 22583779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.